Abstract
Timely diagnosis is a crucial first step for individuals with rare diseases, significantly affecting their access to treatment, care, and overall well-being. Patient organizations have actively engaged in advocating for Newborn Screening (NBS) to raise awareness about rare diseases. This article examines the efforts of six patient organizations worldwide, each functioning as a national, regional or disease-specific alliance with distinct characteristics. These organizations strongly support NBS due to its proven potential to enable early diagnosis and facilitate timely referral to appropriate treatment and care. They employ several approaches to advocate for the expansion of screening panels or implementation of NBS programs, including education, evidence gathering, and fostering multidisciplinary collaboration. There are opportunities to engage the public and emphasize the value of NBS as a public health service that benefits everyone.
Reference40 articles.
1. The importance of psychological support for parents and caregivers of children with a rare disease at diagnosis
2. Greene W. Diagnosing rare diseases shouldn’t be so hard. Available from: https://lableaders.roche.com/global/en/articles/diagnosing-rare-diseases.html [Last accessed on 13 Aug 2024]
3. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
4. Rare Diseases International. Operational description of rare diseases. Available from: https://www.rarediseasesinternational.org/description-for-rd/ [Last accessed on 13 Aug 2024]
5. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)